Cassaday & Co Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Cassaday & Co Wealth Management's ABBV Position: Q3 2026 in Review
Cassaday & Co Wealth Management increased its AbbVie (ABBV) stake by 4% in Q3 2026, buying an estimated $211K and bringing the position to 21,644 shares worth $5.66M. The position accounts for 0.1% of the portfolio, ranked #46.
Cassaday & Co Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 4,272 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Cassaday & Co Wealth Management held 21,644 shares of AbbVie worth $5.66M as of Q3 2026.
- Cassaday & Co Wealth Management bought 824 AbbVie shares in Q3 2026, an estimated $211K.
- AbbVie made up 0.1% of Cassaday & Co Wealth Management's portfolio in Q3 2026, its #46 holding.
- Cassaday & Co Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
- 4,272 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.